What is the climate for getting generic drugs to market in 2014 and what are the obstacles? Polsinelli Shareholder Gary Hood leads the firm's pharmaceutical/Hatch-Waxman patent litigation practice. He has experience in a broad array of civil and criminal matters and now focuses his practice on intellectual property litigation. In this week's "Inside Law" podcast produced by Polsinelli, Hood shares what you should know going into 2014.